Bio-Reference Laboratories, Inc. (BRLI) - Financial and Strategic SWOT Analysis Review
GlobalData
February 6, 2012 40 Pages - SKU: GBDT6797568
|
|
Bio-Reference Laboratories, Inc. (BRLI) - Financial and Strategic SWOT Analysis Review
Summary
Bio-Reference Laboratories, Inc. (Bio-Reference) is a regional clinical laboratory that serves the greater New York metropolitan area. It offers a comprehensive range of laboratory testing services used by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company has a network of 98 patient service centers in the Northeast for collection of patient specimens. Its customer base includes physicians, geneticists, hospitals, clinics, correctional and other health facilities. The company, apart from clinical testing operations, provides clinical knowledge management service through its PSIMedica business unit. Bio-Reference conducts its business in New York, New Jersey, Maryland and some parts of Pennsylvania, Delaware and Connecticut. The company is headquartered in Elmwood Park, New Jersey, the US.
The company's strategy is to provide value-added analytics in conjunction with laboratory results. The company's mission is to capitalize on the clinical market, lead in providing medical information, pursue strategic growth opportunities through development of new testing services and acquisitions.
Bio-Reference Laboratories, Inc. Key Recent Developments
Jan 12, 2012: BRLI Announces Contract With Corizon To Provide Correctional Healthcare Laboratory Services Dec 08, 2011: Bio-Reference Reports Revenue Of $558.6m In Fiscal 2011 Aug 25, 2011: Bio-Reference Reports Net Revenues Of $148m In Q3 Fiscal 2011 May 26, 2011: Bio-Reference Reports Net Revenues Of $137.7m In Q2 Fiscal Year Ended 2011 Mar 03, 2011: Bio-Reference Reports Net Income Of $8m In Q1 Fiscal Year Ended 2011
This comprehensive SWOT profile of Bio-Reference Laboratories, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
|
Section 1 - About the Company - Bio-Reference Laboratories, Inc. - Key Facts
- Bio-Reference Laboratories, Inc. - Key Employees
- Bio-Reference Laboratories, Inc. - Key Employee Biographies
- Bio-Reference Laboratories, Inc. - Major Products and Services
- Bio-Reference Laboratories, Inc. - History
- Bio-Reference Laboratories, Inc. - Company Statement
- Bio-Reference Laboratories, Inc. - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 - Company Analysis
- Bio-Reference Laboratories, Inc. - Business Description
- Bio-Reference Laboratories, Inc. - Corporate Strategy
- Bio-Reference Laboratories, Inc. - SWOT Analysis
- SWOT Analysis - Overview
- Bio-Reference Laboratories, Inc. - Strengths
- Strength - Wide Network of Patient Service Centers
- Strength - Focus on Quality
- Strength - Laboratory Testing Services Portfolio
- Strength - Improving Liquidity Reserves
- Bio-Reference Laboratories, Inc. - Weaknesses
- Weakness - Low Debt to Equity Ratio
- Weakness - Billing Complications
- Weakness - Increasing Trade Receivables
- Bio-Reference Laboratories, Inc. - Opportunities
- Opportunity - Strategic Agreements
- Opportunity - Rising Healthcare Expenditure in the US
- Opportunity - US Clinical Laboratory Testing Market
- Bio-Reference Laboratories, Inc. - Threats
- Threat - Highly Competitive Market
- Threat - Introduction of Innovative Technologies
- Threat - Changing Government Regulations
- Bio-Reference Laboratories, Inc. - Key Competitors
- Section 3 - Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 - Company’s Lifesciences Financial Deals and Alliances
- Bio-Reference Laboratories, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012
- Bio-Reference Laboratories, Inc., Medical Equipment, Deals By Type, 2006 to YTD 2012
- Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
- Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
- Bio-Reference Laboratories, Inc., Recent Deals Summary
- Section 5 - Company’s Recent Developments
- Bio-Reference Laboratories, Inc., Recent Developments
- Jan 12, 2012: BRLI Announces Contract With Corizon To Provide Correctional Healthcare Laboratory Services
- Dec 08, 2011: Bio-Reference Reports Revenue Of $558.6m In Fiscal 2011
- Aug 25, 2011: Bio-Reference Reports Net Revenues Of $148m In Q3 Fiscal 2011
- May 26, 2011: Bio-Reference Reports Net Revenues Of $137.7m In Q2 Fiscal Year Ended 2011
- Mar 03, 2011: Bio-Reference Reports Net Income Of $8m In Q1 Fiscal Year Ended 2011
- Section 6 - Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Bio-Reference Laboratories, Inc., Key Facts
- Bio-Reference Laboratories, Inc., Key Employees
- Bio-Reference Laboratories, Inc., Key Employee Biographies
- Bio-Reference Laboratories, Inc., Major Products and Services
- Bio-Reference Laboratories, Inc., History
- Bio-Reference Laboratories, Inc., Subsidiaries
- Bio-Reference Laboratories, Inc., Key Competitors
- Bio-Reference Laboratories, Inc., Ratios based on current share price
- Bio-Reference Laboratories, Inc., Annual Ratios
- Bio-Reference Laboratories, Inc., Interim Ratios
- Bio-Reference Laboratories, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012
- Bio-Reference Laboratories, Inc., Medical Equipment, Deals By Type, 2006 to YTD 2012
- Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
- Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
- Bio-Reference Laboratories, Inc., Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Bio-Reference Laboratories, Inc., Performance Chart (2007 - 2011)
- Bio-Reference Laboratories, Inc., Ratio Charts
- Bio-Reference Laboratories, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012
- Bio-Reference Laboratories, Inc., Medical Equipment, Deals by Type, 2006 to YTD 2012
- Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
- Bio-Reference Laboratories, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012
Share this report
Other tasks Related Markets Diagnostics Company Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|